PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns. Have an internal positioning decision? The private Sprint uses a separate evidence boundary.

See the private Research Sprint →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION 2h ago7914 SIGNALS8 FEEDS574 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
1001 Opportunity dossier O-1449 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1002 Opportunity dossier O-1448 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1003 Opportunity dossier O-1438 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1004 Opportunity dossier O-1432 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1005 Opportunity dossier O-1418 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1006 Opportunity dossier O-1412 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1007 Opportunity dossier O-1408 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1008 Opportunity dossier O-1403 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1009 Opportunity dossier O-1399 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1010 Opportunity dossier O-1395 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1011 Opportunity dossier O-1393 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1012 Opportunity dossier O-1392 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1013 Opportunity dossier O-1391 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1014 Opportunity dossier O-1390 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1015 Opportunity dossier O-1389 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1016 Opportunity dossier O-1384 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1017 Opportunity dossier O-1381 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1018 Opportunity dossier O-1377 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1019 Opportunity dossier O-1361 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1020 Opportunity dossier O-1359 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.